ID   SK-RC-15
AC   CVCL_6180
SY   SK RC 15
DR   Wikidata; Q54954535
RX   PubMed=2386958;
WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile, exact cancer type and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,14
ST   D18S51: 13,21
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
RX   PubMed=2386958;
RA   Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J.;
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
//